karppaus.infon arkistoitu foorumi

Tänään on 2026-07-21 10:40:43

Kaikki ajat ovat UTC+02:00




Aloita uusi ketju  Vastaa viestiin  [ 1 viesti ] 
Julkaisija Viesti
ViestiLähetetty: 2022-01-21 08:48:25 
Poissa
ruutana
ruutana

Liittynyt: 2007-05-25 15:55:11
Viestit: 29698
Tutkimuskatsaus. Ruokavaliointervention onnistumisen avaintekijäksi pääteltiin beeta-hydroksibutyraattitason monitorointi.

https://sigmapubs.onlinelibrary.wiley.c ... /wvn.12561

Lainaa:
Ketogenic diet, African American women, and cardiovascular health: A systematic review
Audra Hanners DNP, APRN-CNP, Bernadette Melnyk PhD, APRN-CNP, FAANP, FNAP, FAAN, Jeff Volek PhD, RD, Marjorie M. Kelley PhD, MS, RN
First published: 19 January 2022

Abstract
Background

Cardiovascular disease (CVD) is the number one cause of death in the United States of America and across the world. The high prevalence of obesity (56.9%) in African American women contributes to high rates of CVD. Ketogenic nutritional therapy has been shown to be a safe and effective therapy for weight loss and reduction in other CVD risk factors (e.g., HgbA1C and blood pressure). However, the evidence investigating ketogenic nutritional therapy among African American women to improve CVD risk factors has not yet been synthesized.

Aims

To conduct a systematic review of the evidence on CVD risk reduction and ketogenic nutrition therapy among African American women.

Methods

CINAHL Plus, Cochrane, EMBASE, MEDLINE/PubMed, SCOPUS, and Web of Science were searched for quantitative studies focused on ketogenic nutritional therapy and CVD risk factors among African American women. Included studies measured beta-hydroxybutyrate as an indicator of dietary adherence.

Results

Of 4,799 articles identified, six articles representing five studies were included in this review. The majority of participants were female, with very few identified as African American women. Primary outcomes included weight, body mass index (BMI), blood pressure, and lipids. Dietary adherence was difficult to assess. Significant reductions in weight and BMI were noted. Heterogeneity in study design, intervention length, and measurement of dietary adherence made generalizations difficult. Few studies continually monitored dietary adherence using beta-hydroxybutyrate levels, thus threatening the internal validity of the studies. A gap in our understanding remains concerning CVD risk and ketogenic nutritional therapy among African American women specifically.

Linking evidence to action

Ketogenic nutritional therapy is effective in women to reduce weight and BMI. Ketogenic nutritional therapy may be beneficial in reducing CVD risk factors. Monitoring dietary adherence using beta-hydroxybutyrate levels with commercially available monitors is key to intervention success.



Ylös
   
Näytä viestit ajalta:  Järjestä  
Aloita uusi ketju  Vastaa viestiin  [ 1 viesti ] 

Kaikki ajat ovat UTC+02:00


Paikallaolijat

Käyttäjiä lukemassa tätä aluetta: Ei rekisteröityneitä käyttäjiä ja 38 vierailijaa


Et voi kirjoittaa uusia viestejä
Et voi vastata viestiketjuihin
Et voi muokata omia viestejäsi
Et voi poistaa omia viestejäsi
Et voi lähettää liitetiedostoja

Etsi tätä:
Hyppää:  
Keskustelufoorumin ohjelmisto phpBB® Forum Software © phpBB Limited
Käännös: phpBB Suomi (lurttinen, harritapio, Pettis)